Search bioRxiv⌕ Search

Biology subjects

Agas, A.

Publications and source records attributed to Agas, A..

2 recordsLinked to original sources

The beta cell glucocorticoid receptor protects against hyperglycaemia by modulating insulin secretion during glucocorticoid rhythm disruption in mice

Aims/hypothesis: Hyperinsulinaemia is typically viewed as a secondary, compensatory response to insulin resistance or elevated glycaemia. However, we previously found that disrupting the daily glucocorticoid rhythm in mice rapidly increases circulating insulin several-fold while fasting glucose remains normal. This raised the question of what generates and sustains the hyperinsulinaemia. Because glucocorticoids act directly on beta cells through the glucocorticoid receptor (GR), we tested whether beta cell GR is required for this rise in insulin and whether elevated insulin is necessary to maintain glucose homeostasis. Methods: Glucocorticoid rhythms were disrupted in male C57BL/6J mice by subcutaneously implanting corticosterone pellets that raise the trough and lower the peak while maintaining near-physiological mean glucocorticoid exposure, a manipulation we refer to as GC-flattening. Placebo-treated mice served as controls, and high-fat-diet-fed mice provided a metabolic comparison. Beta cell function was assessed by dynamic glucose stimulated insulin secretion and beta cell specific Ca2+ imaging. The requirement for beta cell GR was tested using adult-inducible beta cell specific GR knockout mice, thereby limiting developmental effects of constitutive GR deletion. Combined beta cell and hepatocyte GR knockout mice were used to test the consequences of further reducing systemic insulin availability. Insulin sensitivity and glucose tolerance were assessed in vivo. Insulin clearance was assessed from plasma C-peptide:insulin ratios, direct measurement of the disappearance of intravenously administered human insulin, and hepatic insulin-degrading enzyme abundance and activity. Results: GC-flattening produced rapid, sustained hyperinsulinaemia while blood glucose remained normal, distinct from the more gradual hyperinsulinaemia and hyperglycaemia observed in high-fat-diet-fed mice. Islets from GC-flattened mice retained enhanced insulin secretion and Ca2+ responses to glucose after isolation, indicating a persistent increase in beta cell glucose responsiveness. During GC-flattening, beta cell GR deletion reduced cumulative circulating insulin exposure by approximately 40% (p < 0.001) and worsened glycaemic control despite similar or greater insulin sensitivity, demonstrating that the GR-dependent rise in insulin helps maintain glucose homeostasis. Direct measurement on Day 3 confirmed reduced insulin clearance in GC-flattened mice. This was accompanied by a reduced plasma C-peptide-to-insulin ratio and decreased hepatic insulin-degrading enzyme abundance and activity. Further lowering circulating insulin by combined beta cell and hepatocyte GR deletion worsened glycaemic control further. Conclusions/interpretation: Disruption of glucocorticoid rhythmicity directly initiates hyperinsulinaemia by enhancing glucose-stimulated insulin secretion through beta cell GR signalling and by reducing insulin clearance. The resulting increase in insulin is required to maintain glucose homeostasis, demonstrating that hyperinsulinaemia can be an early adaptive response to altered endocrine timing rather than simply a consequence of insulin resistance or hyperglycaemia.

physiology↗

High fat diet but not glucocorticoid-induced obesity results in fatty liver

Chronic stress, modeled by flattened circadian glucocorticoid (GC) oscillations, is increasingly implicated in obesity. We investigated the underlying mechanisms by disrupting GC rhythms in mice, elevating normally low GC levels during the rest period. This disruption induced substantial obesity, comparable to a 60% high-fat diet (HFD), with additive effects on fat mass, suggesting distinct mechanisms driving adiposity. Despite similar adiposity, GC-flattening and HFD produced profoundly different metabolic outcomes. HFD led to hepatic steatosis and elevated fasting glucose/fatty acid levels, reflecting typical diet-induced dysfunction. In contrast, GC-flattening maintained low fasting glucose/fatty acid levels and prevented hepatic lipid accumulation, with increased adiposity driven by a shift of glucose uptake from muscle to fat and suppression of lipolysis. This reveals a previously unrecognized mechanism of obesity development where excess fat accumulation occurs independently of the mechanisms driving metabolic dysfunction observed in diet-induced obesity. The dissociation between obesity and metabolic dysfunction in GC-flattening challenges the view that increased adiposity and persistent hyperinsulinemia inevitably leads to fatty liver disease. Understanding this pathway opens avenues for novel therapeutic interventions targeting stress-related metabolic disorders.

physiology↗